Neogen ROA 2010-2025 | NEOG
Current and historical return on assets (ROA) values for Neogen (NEOG) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Neogen ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-05-31 | $-1.09B | $3.44B | -27.24% |
| 2025-02-28 | $-0.49B | $4.04B | -11.32% |
| 2024-11-30 | $-0.48B | $4.05B | -10.76% |
| 2024-08-31 | $-0.02B | $4.50B | -0.50% |
| 2024-05-31 | $-0.01B | $4.55B | -0.17% |
| 2024-02-29 | $0.00B | $4.58B | 0.07% |
| 2023-11-30 | $0.01B | $4.60B | 0.29% |
| 2023-08-31 | $-0.03B | $4.56B | -0.57% |
| 2023-05-31 | $-0.02B | $4.55B | -0.63% |
| 2023-02-28 | $-0.01B | $4.51B | -0.51% |
| 2022-11-30 | $-0.02B | $4.56B | -0.90% |
| 2022-08-31 | $0.04B | $0.98B | 3.67% |
| 2022-05-31 | $0.05B | $0.99B | 4.96% |
| 2022-02-28 | $0.05B | $0.98B | 5.16% |
| 2021-11-30 | $0.06B | $0.97B | 6.16% |
| 2021-08-31 | $0.06B | $0.93B | 6.93% |
| 2021-05-31 | $0.06B | $0.92B | 7.04% |
| 2021-02-28 | $0.06B | $0.88B | 7.29% |
| 2020-11-30 | $0.06B | $0.85B | 7.41% |
| 2020-08-31 | $0.06B | $0.82B | 7.63% |
| 2020-05-31 | $0.06B | $0.80B | 7.76% |
| 2020-02-29 | $0.06B | $0.77B | 8.02% |
| 2019-11-30 | $0.06B | $0.75B | 8.45% |
| 2019-08-31 | $0.06B | $0.72B | 8.73% |
| 2019-05-31 | $0.06B | $0.70B | 8.99% |
| 2019-02-28 | $0.06B | $0.67B | 9.57% |
| 2018-11-30 | $0.07B | $0.66B | 10.50% |
| 2018-08-31 | $0.07B | $0.64B | 11.00% |
| 2018-05-31 | $0.06B | $0.62B | 10.93% |
| 2018-02-28 | $0.06B | $0.60B | 10.30% |
| 2017-11-30 | $0.05B | $0.58B | 9.43% |
| 2017-08-31 | $0.05B | $0.55B | 8.70% |
| 2017-05-31 | $0.04B | $0.53B | 8.64% |
| 2017-02-28 | $0.04B | $0.51B | 8.57% |
| 2016-11-30 | $0.04B | $0.49B | 8.49% |
| 2016-08-31 | $0.04B | $0.47B | 8.33% |
| 2016-05-31 | $0.04B | $0.45B | 8.39% |
| 2016-02-29 | $0.04B | $0.43B | 8.44% |
| 2015-11-30 | $0.03B | $0.43B | 8.47% |
| 2015-08-31 | $0.03B | $0.41B | 8.54% |
| 2015-05-31 | $0.03B | $0.39B | 8.84% |
| 2015-02-28 | $0.03B | $0.38B | 8.85% |
| 2014-11-30 | $0.03B | $0.37B | 9.15% |
| 2014-08-31 | $0.03B | $0.36B | 8.87% |
| 2014-05-31 | $0.03B | $0.35B | 8.90% |
| 2014-02-28 | $0.03B | $0.33B | 8.97% |
| 2013-11-30 | $0.03B | $0.32B | 9.33% |
| 2013-08-31 | $0.03B | $0.31B | 10.09% |
| 2013-05-31 | $0.03B | $0.29B | 10.15% |
| 2013-02-28 | $0.03B | $0.28B | 10.15% |
| 2012-11-30 | $0.03B | $0.27B | 9.78% |
| 2012-08-31 | $0.02B | $0.26B | 9.32% |
| 2012-05-31 | $0.02B | $0.25B | 9.22% |
| 2012-02-29 | $0.02B | $0.24B | 9.54% |
| 2011-11-30 | $0.02B | $0.23B | 9.88% |
| 2011-08-31 | $0.02B | $0.23B | 10.69% |
| 2011-05-31 | $0.02B | $0.22B | 11.17% |
| 2011-02-28 | $0.02B | $0.21B | 11.22% |
| 2010-11-30 | $0.02B | $0.20B | 11.35% |
| 2010-08-31 | $0.02B | $0.19B | 11.48% |
| 2010-05-31 | $0.02B | $0.18B | 10.94% |
| 2010-02-28 | $0.02B | $0.17B | 10.32% |
| 2009-11-30 | $0.02B | $0.16B | 10.08% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.203B | $0.895B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.730B | 26.59 |
| Boston Scientific (BSX) | United States | $152.695B | 36.41 |
| Stryker (SYK) | United States | $145.892B | 29.70 |
| EssilorLuxottica (ESLOY) | France | $145.168B | 0.00 |
| Medtronic (MDT) | Ireland | $118.964B | 16.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.349B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.447B | 24.82 |
| ResMed (RMD) | United States | $41.892B | 29.96 |
| Agilent Technologies (A) | United States | $33.562B | 21.88 |
| GE HealthCare Technologies (GEHC) | United States | $33.407B | 15.70 |
| Terumo (TRUMY) | Japan | $27.938B | 33.10 |
| Koninklijke Philips (PHG) | Netherlands | $26.432B | 17.48 |
| Insulet (PODD) | United States | $22.742B | 76.20 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.317B | 12.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.894B | 0.00 |
| Baxter (BAX) | United States | $12.127B | 9.37 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.703B | 28.30 |
| Lantheus Holdings (LNTH) | United States | $3.806B | 10.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.452B | 24.15 |
| Prestige Consumer Healthcare (PBH) | United States | $3.193B | 14.16 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $3.035B | 20.67 |
| Haemonetics (HAE) | United States | $2.559B | 11.42 |
| LeMaitre Vascular (LMAT) | United States | $2.151B | 46.14 |
| Curaleaf Holdings (CURLF) | Canada | $1.944B | 0.00 |
| AtriCure (ATRC) | United States | $1.770B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.753B | 11.03 |
| Green Thumb Industries (GTBIF) | United States | $1.751B | 75.18 |
| AdaptHealth (AHCO) | United States | $1.269B | 18.04 |
| Phibro Animal Health (PAHC) | United States | $1.267B | 16.19 |
| Tilray Brands (TLRY) | Canada | $1.255B | 0.00 |
| Acuren (TIC) | United States | $1.182B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.174B | 2450.00 |
| Valneva SE (VALN) | France | $1.033B | 0.00 |
| InMode (INMD) | Israel | $0.904B | 8.37 |
| Kestra Medical Technologies (KMTS) | United States | $0.826B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.654B | 0.00 |
| SNDL (SNDL) | Canada | $0.568B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.557B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.506B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.458B | 15.76 |
| CeriBell (CBLL) | United States | $0.447B | 0.00 |
| Evolus (EOLS) | United States | $0.433B | 0.00 |
| Owens & Minor (OMI) | United States | $0.421B | 3.73 |
| Capricor Therapeutics (CAPR) | United States | $0.352B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.298B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.289B | 0.00 |
| Omeros (OMER) | United States | $0.288B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Brainsway (BWAY) | Israel | $0.281B | 57.12 |
| Viemed Healthcare (VMD) | United States | $0.268B | 20.35 |
| Vireo Growth (VREOF) | United States | $0.244B | 0.00 |
| High Tide (HITI) | Canada | $0.242B | 0.00 |
| Cerus (CERS) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| Exagen (XGN) | United States | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.28 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.36 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.121B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.07 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.16 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.046B | 35.83 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 13.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |